Rebecca Sleigh

Statistics

Publications

Citations

250

H-Index

Active since

2015

Affiliations

Cambridge University Hospitals NHS Foundation Trust(Current)

Cancer Research UK

NHS Lothian

AstraZeneca (United Kingdom)

University of Glasgow

Rebecca Sleigh is an author at Cambridge University Hospitals NHS Foundation Trust specializing in pharmacology, temozolomide therapy, and glioblastoma drug therapy.

Publications per year

2015–2020

Publications

Pharmacokinetics, safety, and tolerability of olaparib and temozolomide for recurrent glioblastoma: results of the phase I OPARATIC trial

Catherine Hanna, Kathreena M. Kurian, Karin Williams et al. · Neuro-Oncology · 2020 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Determination of Avibactam and Ceftazidime in Human Plasma Samples by LC–MS

Henrik Sillén, Richard Mitchell, Rebecca Sleigh et al. · Bioanalysis · 2015 · 52 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Results of the OPARATIC trial: A phase I dose escalation study of olaparib in combination with temozolomide (TMZ) in patients with relapsed glioblastoma (GBM).

Sarah Halford, Garth Cruickshank, Laurence Dunn et al. · Journal of Clinical Oncology · 2017 · 33 citations

Medicine, Oncology, Pharmacology +15

ACTR-16. RESULTS OF THE OPARATIC TRIAL: A PHASE I DOSE ESCALATION STUDY OF OLAPARIB IN COMBINATION WITH TEMOZOLOMIDE (TMZ) IN PATIENTS WITH RELAPSED GLIOBLASTOMA (GBM)

Anthony J. Chalmers, Garth Cruickshank, Laurence Dunn et al. · Neuro-Oncology · 2017 · 15 citations · Full text

Medicine, Oncology, Pharmacology +17

1–4 of 4